Inactive Instrument

Calendar ASKA Pharmaceutical Co., Ltd. Japan Exchange

Equities

4514

JP3541200006

Chart calendar ASKA Pharmaceutical Co., Ltd.

1474b0c9d5ff08057b8016bbbfe.GqKiI9BOUnBcUnsL-6sXSIQNxfnZleSbCKyhG_8o4eo.XtvhZqAlPDsMMQ1Ziu1lGedHgZWb4pDpecmTWJhPqqRM-tBLtgAgH3EGLg~7a7f7265be1341e6a04bf478aa9828c0

Upcoming events on ASKA Pharmaceutical Co., Ltd.

05/08/2024 Q1 2024 Earnings Release (Projected)
04/11/2024 Q2 2024 Earnings Release (Projected)
10/02/2025 Q3 2024 Earnings Release (Projected)
08/05/2025 Q4 2025 Earnings Release (Projected)

Past events on ASKA Pharmaceutical Co., Ltd.

10/05/2024 Q4 2023 Earnings Release
05/02/2024 Q3 2023 Earnings Release
06/11/2023 Q2 2023 Earnings Release
07/08/2023 Q1 2023 Earnings Release
11/05/2023 Q4 2022 Earnings Release
06/02/2023 Q3 2022 Earnings Release
07/11/2022 Interim 2022 Earnings Release
08/08/2022 Q1 2022 Earnings Release
12/05/2022 FY 2021 Earnings Release
07/02/2022 Q3 2022 Earnings Release
01/11/2021 Interim 2021 Earnings Release
02/08/2021 Q1 2021 Earnings Release

Annual results

Fiscal PeriodMarch 2019 2020 2021 2022 2023 2024
Net sales
Million JPY
Released
Forecast
Spread
46 706
48 500
-3.7%
52 542
52 500
0.08%
55 181
55 100
0.15%
56 607
57 000
-0.69%
60 461
60 300
0.27%
62 843
63 285
-0.7%
EBITDA
Million JPY
Released
Forecast
Spread
4 273
4 400
-2.89%
5 268
5 300
-0.6%
6 915
6 999
-1.2%
13 633
14 600
-6.62%
8 235
8 590
-4.13%
9 162
8 984
1.98%
EBIT
Million JPY
Released
Forecast
Spread
1 782
2 100
-15.14%
1 507
1 500
0.47%
3 609
3 600
0.25%
4 795
4 500
6.56%
5 108
5 300
-3.62%
6 500
5 688
14.27%
Earnings before Tax (EBT)
Million JPY
Released
Forecast
Spread
1 883
1 950
-3.44%
901
1 000
-9.9%
3 575
3 300
8.33%
6 163
5 600
10.05%
5 357
5 450
-1.71%
9 862
8 571
15.06%
Net income
Million JPY
Released
Forecast
Spread
1 744
1 650
5.7%
649
600
8.17%
2 713
2 700
0.48%
4 290
4 000
7.25%
4 238
4 250
-0.28%
7 545
6 466
16.68%
EPS
JPY
Released
Forecast
Spread
61,8
58,4
5.84%
23,0
21,2
8.3%
95,7
95,2
0.55%
151
141
7.4%
150
150
-0.15%
267
228
16.65%
Announcement Date10/05/1912/05/2011/05/2112/05/2211/05/2310/05/24

Quarterly results

Fiscal PeriodMarch 2020 S1 2021 S1 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 S1 2025 Q3 2025 Q4
Net sales
Million JPY
Released
Forecast
Spread
26 582
27 300
-2.63%
27 403
27 100
1.12%
28 477
27 310
4.27%
15 702
15 123
3.83%
12 428
12 821
-3.07%
15 269
14 750
3.52%
14 903
14 631
1.86%
30 172
29 900
0.91%
17 087
16 828
1.54%
13 202
13 041
1.23%
16 023


15 625
15 677
-0.33%
31 648
31 700
-0.16%
17 176
17 430
-1.46%
14 019
14 176
-1.11%

16 285


16 030


32 617


17 540


14 510

EBIT
Million JPY
Released
Forecast
Spread
746
1 600
-53.38%
1 946
1 040
87.12%
2 657
1 700
56.29%
2 020
1 343
50.41%
118
-177
166.67%
1 664
1 050
58.48%
1 215
1 036
17.28%
2 879
2 700
6.63%
2 162
2 171
-0.41%
67,0
259
-74.13%
1 704


1 351
1 506
-10.29%
3 055
3 210
-4.83%
2 471
2 300
7.43%
974
74,0
1216.22%

1 833


1 500


3 462


2 690


840

Earnings before Tax (EBT)
Million JPY
Released
Forecast
Spread
918


1 952
990
97.17%
-4 139


9 988





1 805


1 214
945
28.47%
3 019
2 750
9.78%
2 348
2 163
8.55%



1 873





5 410


3 110




















Net income
Million JPY
Released
Forecast
Spread
577
1 000
-42.3%
1 552
780
98.97%
-2 796
-4 000
30.1%
6 878
596
1054.03%
208
-82,0
353.66%
1 323


1 023
795
28.68%
2 346
2 118
10.76%
1 837
1 723
6.62%
55,0
67,0
-17.91%
1 428


2 701
2 372
13.87%
4 129
3 800
8.66%
2 329
2 400
-2.96%
1 087
-108
1106.48%

1 395


1 140


2 635


2 044


668

EPS
JPY
Released
Forecast
Spread
20,4


54,8


-98,5


242





46,9





83,2


65,0





50,5





146


82,2






43,8





89,5







Announcement Date05/11/1904/11/2001/11/2107/02/2212/05/2208/08/2207/11/2207/11/2206/02/2311/05/2307/08/2306/11/2306/11/2305/02/2410/05/24-----
  1. Stock Market
  2. Equities
  3. 4886 Stock
  4. 4514 Stock
  5. Calendar ASKA Pharmaceutical Co., Ltd.